Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Antiretroviral
14%
CD4 Cell Count
28%
CD4+ T
14%
Cell Count
14%
Daily Dose
14%
Dose Escalation
14%
Dosing Regimen
14%
Gp120
14%
Hepatic Clearance
14%
HIV-1 Fusion Inhibitor
100%
HIV-infected Patients
14%
Human Immunodeficiency Virus Type 1 (HIV-1)
14%
Human Serum Albumin
100%
IC50
14%
Infected Individual
14%
Laboratory Assessment
14%
Liver Transaminases
28%
Monkey
14%
Mouse Model
14%
Multiple Dose
14%
Multiple Dosing
42%
Negatively Charged
14%
Neoglycoprotein
14%
Pharmacokinetics
14%
Phase I/IIa Study
100%
Plasma HIV-1 RNA
14%
Plasma Parameters
71%
Positively Charged
14%
Single Dosing
14%
Single-dose Studies
14%
Target Concentration
14%
Target Plasma Concentration
14%
Trough Level
14%
V3 Loop
14%
Immunology and Microbiology
Albumin
100%
Blood Level
85%
Blood Plasma
14%
CD4 Lymphocyte Count
42%
Glycoprotein
14%
Hepatic Clearance
14%
Human Immunodeficiency Virus 1
100%
IC50
14%
In Vitro
14%
Mouse Model
14%
Multiple Drug Dose
14%
Pharmacokinetic
14%
Rat
14%
Ribonucleic Acid
14%
Serum (Blood)
100%
Biochemistry, Genetics and Molecular Biology
Blood Level
85%
Blood Plasma
14%
CD4 Lymphocyte Count
42%
Glycoprotein
14%
Hepatic Clearance
14%
Human Immunodeficiency Virus 1
100%
Human Serum Albumin
100%
IC50
14%
Mouse Model
14%
Multiple Drug Dose
14%
Pharmacokinetic
14%
Rat
14%
RNA
14%
Single Drug Dose
71%
Transaminase
28%
Pharmacology, Toxicology and Pharmaceutical Science
Aminotransferase
28%
Antivirus Agent
14%
Glycoprotein
14%
HIV
100%
Human Immunodeficiency Virus Fusion Inhibitor
100%
Human Serum Albumin
100%
IC50
14%
Mouse Model
14%
Pharmacokinetic
14%
Rat
14%
Trough Level
14%